EcoDrugPlus

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSCPOG00000011339
Gene Symbol: TRHR
2 Cross references
269 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSCPOG00000025374
Gene Symbol: TLR2
2 Cross references
249 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSCPOG00000015159
Gene Symbol: TLR4
2 Cross references
127 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSCPOG00000038746
Gene Symbol: TLR7
2 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSCPOG00000004761
Gene Symbol: TLR8
4 Cross references
199 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSCPOG00000034913
Gene Symbol: TLR9
2 Cross references
82 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCPOG00000001949
Gene Symbol: TAAR1
4 Cross references
600 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSCPOG00000014890
Gene Symbol: TGFBR1
4 Cross references
236 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSCPOG00000011519
Gene Symbol: TRPA1
3 Cross references
228 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSCPOG00000005510
Gene Symbol: TRPM8
3 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSCPOG00000010142
Gene Symbol: TRPV1
2 Cross references
134 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSCPOG00000031571
Gene Symbol: TSPO
2 Cross references
122 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).